152 related articles for article (PubMed ID: 16511443)
1. A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(8):209-10. PubMed ID: 16511443
[TBL] [Abstract][Full Text] [Related]
2. FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(12):212. PubMed ID: 22456121
[TBL] [Abstract][Full Text] [Related]
3. Updated recommendations for use of VariZIG--United States, 2013.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jul; 62(28):574-6. PubMed ID: 23863705
[TBL] [Abstract][Full Text] [Related]
4. VariZIG for prophylaxis after exposure to varicella.
Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):69-70. PubMed ID: 16977283
[No Abstract] [Full Text] [Related]
5. Serum concentrations, efficacy, and safety of a new, intravenously administered varicella zoster immune globulin in pregnant women.
Koren G; Money D; Boucher M; Aoki F; Petric M; Innocencion G; Wolosk M; Remple V; Pelland F; Geist R; Ho T; Bar-Oz B; Loebstein R
J Clin Pharmacol; 2002 Mar; 42(3):267-74. PubMed ID: 11865962
[TBL] [Abstract][Full Text] [Related]
6. Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program.
Levin MJ; Duchon JM; Swamy GK; Gershon AA
PLoS One; 2019; 14(7):e0217749. PubMed ID: 31269033
[TBL] [Abstract][Full Text] [Related]
7. Varicella-zoster immune globulin for the prevention of chickenpox. Recommendations of the Immunization Practices Advisory Committee, Centers for Disease Control.
Ann Intern Med; 1984 Jun; 100(6):859-65. PubMed ID: 6326634
[TBL] [Abstract][Full Text] [Related]
8. Towards evidence based medicine for paediatricians. How effective is varicella-zoster immunoglobulin (VZIG) in preventing chickenpox in neonates following perinatal exposure?
Tebruegge M; Pantazidou A; Curtis N
Arch Dis Child; 2009 Jul; 94(7):559-61. PubMed ID: 19542068
[No Abstract] [Full Text] [Related]
9. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
10. The role of VariZIG in pregnancy.
Bapat P; Koren G
Expert Rev Vaccines; 2013 Nov; 12(11):1243-8. PubMed ID: 24093779
[TBL] [Abstract][Full Text] [Related]
11. Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(10):299. PubMed ID: 20300057
[TBL] [Abstract][Full Text] [Related]
12. Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.
Duchon JM; Levin MJ; Gershon AA
J Pediatric Infect Dis Soc; 2020 Sep; 9(4):449-453. PubMed ID: 31774916
[TBL] [Abstract][Full Text] [Related]
13. Varicella zoster immunoglobulin after postnatal exposure to varicella: survey of experts.
Wurzel CL; Rubin LG; Krilov LR
Pediatr Infect Dis J; 1987 May; 6(5):466-70. PubMed ID: 3037474
[TBL] [Abstract][Full Text] [Related]
14. Neonatal varicella: varicella zoster immunoglobulin (VZIG) does not prevent disease.
Reynolds L; Struik S; Nadel S
Arch Dis Child Fetal Neonatal Ed; 1999 Jul; 81(1):F69-70. PubMed ID: 10375368
[TBL] [Abstract][Full Text] [Related]
15. Varicella-zoster immune globulin--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1981 Jan; 30(2):15-6, 21-3. PubMed ID: 6789088
[No Abstract] [Full Text] [Related]
16. [Use of Varitect in the prevention of diseases in children caused by varicella-zoster viruses].
Bartosová D; Wiedermannová D
Cesk Pediatr; 1993 May; 48(5):275-7. PubMed ID: 8374966
[TBL] [Abstract][Full Text] [Related]
17. Uses of immune globulins in the prophylaxis and treatment of viral infections.
Weintrub PS
Clin Lab Med; 1987 Dec; 7(4):897-910. PubMed ID: 2826075
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of oral aciclovir in preventing maternal chickenpox: A comparison with VZIG.
Sile B; Brown KE; Gower C; Bosowski J; Dennis A; Falconer M; Stowe J; Andrews N; Amirthalingam G
J Infect; 2022 Aug; 85(2):147-151. PubMed ID: 35659543
[TBL] [Abstract][Full Text] [Related]
19. Charging for investigational drugs under an investigational new drug application. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
[TBL] [Abstract][Full Text] [Related]
20. PEPtalk: postexposure prophylaxis against varicella in children with cancer.
Bate J; Chisholm J; Heath PT; Breuer J; Skinner R; Manley S; Patel S; Wheatley K; Ramsay M; Kearns PR; Hambleton S
Arch Dis Child; 2011 Sep; 96(9):841-5. PubMed ID: 21715391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
